Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001609623-14-000002
Filing Date
2014-06-04
Accepted
2014-06-04 09:51:57
Documents
1
Effectiveness Date
2014-06-04
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6900
  Complete submission text file 0001609623-14-000002.txt   8009
Mailing Address 404 UNDERHILL ROAD SCARSDALE NY 10583
Business Address 404 UNDERHILL ROAD SCARSDALE NY 10583 (914) 263-2303
Remiges BioPharma Fund, LP (Filer) CIK: 0001609623 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-218532 | Film No.: 14889502